• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性肿瘤刮除术后骨填充的治疗选择及临床结果。一项系统评价。

Treatment alternatives and clinical outcomes of bone filling after benign tumour curettage. A systematic review.

作者信息

Gava Nelson Fabrício, Engel Edgard Eduard

机构信息

Department of Biomechanics, Medicine and Rehabilitation of the Locomotor System, Clinical Hospital, Ribeirão Preto Medical School, University of São Paulo, 3900, Bandeirantes avenue, 11th floor, 14040-030, Ribeirão Preto, São Paulo, Brazil.

Department of Biomechanics, Medicine and Rehabilitation of the Locomotor System, Clinical Hospital, Ribeirão Preto Medical School, University of São Paulo, 3900, Bandeirantes avenue, 11th floor, 14040-030, Ribeirão Preto, São Paulo, Brazil.

出版信息

Orthop Traumatol Surg Res. 2022 Jun;108(4):102966. doi: 10.1016/j.otsr.2021.102966. Epub 2021 May 24.

DOI:10.1016/j.otsr.2021.102966
PMID:34033919
Abstract

BACKGROUND

Benign and pseudo-neoplastic bone lesions are usually treated by curettage and filling of the cavity. This filling is usually achieved with the use of autologous bone grafts, bone cement, allografts, xenografts, or synthetic bone substitutes. Recently, some authors have suggested that these defects do not require filling for consolidation but the respective rate of complications of each method is not well defined. Therefore, we did a systematic review aiming to answer: (1) Not filling bone cavities after benign bone tumour curettage may increase the rate of fractures? (2) Can the volume of the bone defect in itself be a specific or reliable predictor of fracture? (3) Does the mean functional outcome, recurrence, non-weight bearing time, other postoperative complications or bone consolidation time vary between the methods of filling?

PATIENTS AND METHODS

The PubMed (2407 articles) and Latin American and Caribbean Health Sciences Literature (LILACS) (50 articles) databases were reviewed, without restriction considering publication date. After exclusion criteria, 62 articles were selected for data collection. Filling or not filling (UN), methods of filling, fracture rate, bone defect size, mean functional outcome, recurrence, non-weight bearing time, other postoperative complications, consolidation time were the data of interest.

RESULTS

The number of patients was 2555 distributed among the different filling methods. Unfilled cavities were associated with higher fracture rate [20/302 (6.62%)] versus 4/189 (2.12%) for allografts, 14/343 (4.08%) for cement filling, 4/247 for autograft (1.62%), and 12/580 (2.07%) for bone substitute. The volume of the bone defect alone is not a specific or reliable predictor of fracture. All filling methods were similar regarding the mean functional outcome, recurrence rate and consolidation time. The bone cement allowed early weight bearing time (mean of weeks): UN: 9.67; autologous bone grafts: 9.8; bone cement: 0.5; allografts: 9.0; synthetic bone substitutes: 9.96.

CONCLUSION

Not filling the bone cavity after benign bone tumour curettage is an alternative, but can increase fracture rate, even in small volume bone defects. The use of prophylactic fixation drastically reduces the fracture rate. Filling with cement reduces weight bearing time. There are little differences between the methods used to fill, even compared to not filling the cavity.

LEVEL OF EVIDENCE

III; systematic review.

摘要

背景

良性和假性肿瘤性骨病变通常通过刮除和填充骨腔来治疗。这种填充通常使用自体骨移植、骨水泥、同种异体骨移植、异种骨移植或合成骨替代物来实现。最近,一些作者认为这些骨缺损无需填充即可实现骨愈合,但每种方法的并发症发生率尚未明确界定。因此,我们进行了一项系统评价,旨在回答以下问题:(1)良性骨肿瘤刮除术后不填充骨腔是否会增加骨折发生率?(2)骨缺损的体积本身是否是骨折的特异性或可靠预测指标?(3)不同填充方法之间的平均功能结局、复发率、非负重时间、其他术后并发症或骨愈合时间是否存在差异?

患者和方法

检索了PubMed(2407篇文章)和拉丁美洲及加勒比地区健康科学文献数据库(LILACS)(50篇文章),检索时不考虑发表日期。经过排除标准筛选后,选取62篇文章进行数据收集。填充或不填充(UN)、填充方法、骨折发生率、骨缺损大小、平均功能结局、复发率、非负重时间、其他术后并发症、骨愈合时间是感兴趣的数据。

结果

2555例患者分布于不同的填充方法中。未填充骨腔的骨折发生率较高[20/302(6.62%)],而异种骨移植为4/189(2.12%),骨水泥填充为14/343(4.08%),自体骨移植为4/247(1.62%),骨替代物为12/580(2.07%)。单纯骨缺损的体积不是骨折的特异性或可靠预测指标。所有填充方法在平均功能结局、复发率和骨愈合时间方面相似。骨水泥允许早期负重时间(平均周数):未填充:9.67;自体骨移植:9.8;骨水泥:0.5;异种骨移植:9.0;合成骨替代物:9.96。

结论

良性骨肿瘤刮除术后不填充骨腔是一种选择,但即使在小体积骨缺损中也会增加骨折发生率。使用预防性内固定可显著降低骨折发生率。骨水泥填充可缩短负重时间。即使与不填充骨腔相比,不同填充方法之间也几乎没有差异。

证据级别

III级;系统评价。

相似文献

1
Treatment alternatives and clinical outcomes of bone filling after benign tumour curettage. A systematic review.良性肿瘤刮除术后骨填充的治疗选择及临床结果。一项系统评价。
Orthop Traumatol Surg Res. 2022 Jun;108(4):102966. doi: 10.1016/j.otsr.2021.102966. Epub 2021 May 24.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Guided tissue regeneration for periodontal infra-bony defects.牙周骨下袋缺损的引导组织再生术。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD001724. doi: 10.1002/14651858.CD001724.pub2.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Bioengineered nerve conduits and wraps for peripheral nerve repair of the upper limb.生物工程神经导管和套用于上肢周围神经修复。
Cochrane Database Syst Rev. 2022 Dec 7;12(12):CD012574. doi: 10.1002/14651858.CD012574.pub2.
6
Interventions for infantile haemangiomas of the skin.皮肤婴儿血管瘤的干预措施。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD006545. doi: 10.1002/14651858.CD006545.pub3.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Direct composite resin fillings versus amalgam fillings for permanent posterior teeth.直接复合树脂充填与银汞合金充填用于永久性后牙。
Cochrane Database Syst Rev. 2021 Aug 13;8(8):CD005620. doi: 10.1002/14651858.CD005620.pub3.
9
Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review.骨形态发生蛋白在骨折不愈合和脊柱融合中的临床疗效及成本效益:一项系统评价
Health Technol Assess. 2007 Aug;11(30):1-150, iii-iv. doi: 10.3310/hta11300.
10
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.

引用本文的文献

1
Can bioactive glass replace bone grafts after curettage of benign bone Tumors? A systematic review and meta-analysis of randomized controlled trials.生物活性玻璃能替代良性骨肿瘤刮除术后的骨移植吗?一项随机对照试验的系统评价和荟萃分析。
J Orthop. 2025 Jun 3;69:208-215. doi: 10.1016/j.jor.2025.05.061. eCollection 2025 Nov.
2
Fixation with Carbon Fiber Plates After Curettage in Benign and Locally Aggressive Bone Tumors: Clinical and Radiographic Outcomes.刮除术后使用碳纤维板固定治疗良性及局部侵袭性骨肿瘤:临床及影像学结果
J Clin Med. 2025 Mar 29;14(7):2371. doi: 10.3390/jcm14072371.
3
Clinical efficacy of allograft bone combined with calcium phosphate bone powder in repairing bone defects of benign bone tumors: A retrospective controlled study.
同种异体骨联合磷酸钙骨粉修复良性骨肿瘤骨缺损的临床疗效:一项回顾性对照研究。
BMC Surg. 2025 Mar 14;25(1):99. doi: 10.1186/s12893-025-02823-x.
4
Incorporation of black phosphorus nanosheets into poly(propylene fumarate) biodegradable bone cement to enhance bioactivity and osteogenesis.将黑磷纳米片掺入聚(富马酸丙二醇酯)可生物降解骨水泥中以增强生物活性和骨生成。
J Orthop Surg Res. 2024 Jan 30;19(1):98. doi: 10.1186/s13018-024-04566-6.
5
Effect of Local Adjuvants Following Curettage of Benign and Intermediate Tumours of Bone: A Systematic Review of the Literature.骨良性和中间性肿瘤刮除术后局部佐剂的作用:文献系统评价
Cancers (Basel). 2023 Aug 25;15(17):4258. doi: 10.3390/cancers15174258.
6
Artificial Bone Graft Substitutes for Curettage of Benign and Low-Grade Malignant Bone Tumors: Clinical and Radiological Experience with Cerasorb.用于刮除良性和低度恶性骨肿瘤的人工骨移植替代物:Cerasorb的临床和放射学经验
Indian J Orthop. 2023 Jun 22;57(9):1409-1414. doi: 10.1007/s43465-023-00919-1. eCollection 2023 Sep.
7
Injectable Synthetic Beta-Tricalcium Phosphate/Calcium Sulfate (GeneX) for the Management of Contained Defects Following Curettage of Benign Bone Tumours.可注射合成β-磷酸三钙/硫酸钙(GeneX)在良性骨肿瘤刮除术后的含腔缺损治疗中的应用。
Curr Oncol. 2023 Mar 27;30(4):3697-3707. doi: 10.3390/curroncol30040281.
8
Bovine Grafting: An Effective Alternative after Curettage of Benign Bone Tumors.牛骨移植:良性骨肿瘤刮除术后的一种有效替代方法。
Life (Basel). 2023 Mar 15;13(3):789. doi: 10.3390/life13030789.